SAN DIEGO--(BUSINESS WIRE)--A Notice of Allowance was issued to the University of California by the United States Patent & Trademark Office (“USPTO”) for composition of matter claims pending in a patent application licensed by Cytori Therapeutics (NASDAQ: CYTX). The allowed claims cover a population of stem cells, progenitor cells and other replicating cells, which can be obtained from human adipose tissue.
